Guidelines: Difference between revisions

From UrologySchool.com
Jump to navigation Jump to search
Newer edit →
VisualWikitext
Created page with "== AUA == === Oncology === ==== Prostate ==== * Advanced Prostate Cancer (2020) * Adjuvant and Salvage Radiotherapy After Prostatectomy (2019) * Prostate Cancer Screening (2018) * Clinically Localized Prostate Cancer (2017) ==== Bladder ==== * Microscopic Hematuria (2020) * Muscle-invasive Bladder Cancer (2017) * Non-muscle Invasive Bladder Cancer (2016) ==== Kidney ==== * Renal Mass and Localized Renal Cancer (2021) ==== Testicular ==== * (2019) Included in Tes..."
 
Line 66: Line 66:


=== Oncology ===
=== Oncology ===
Prostate Castrate-resistant Prostate Cancer (2021)


Androgen Deprivation Therapy: Adverse Events & Management (2021)
==== Prostate ====


Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)
* Castrate-resistant Prostate Cancer (2021)
* Androgen Deprivation Therapy: Adverse Events & Management (2021)
* Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)
* Testosterone Suppression (2018)
* Prostate Cancer Screening (2017)
* Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)
* Prostate Cancer Active Surveillance (2015)


Testosterone Suppression (2018)
==== Bladder ====


Prostate Cancer Screening (2017)
* Non-muscle Invasive Bladder Cancer (2021)
* Advanced and Metastatic Urothelial Cancer (2019)
* Muscle-invasive Bladder Cancer (2019)
* Asymptomatic Mircoscopic Hematuria (2008)


Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)
==== Kidney ====


Prostate Cancer Active Surveillance (2015)
* Follow-up Localized RCC (2018)
* Cystic Renal Lesions (2017)
* Small Renal Masses (2015)
* Surgical Management of RCC (2014)
* RCC Genetic Screening (2013)


Bladder Non-muscle Invasive Bladder Cancer (2021)
=== Non-oncology ===


Advanced and Metastatic Urothelial Cancer (2019)
==== Andrology ====


Muscle-invasive Bladder Cancer (2019)
* Peyronie's Disease (2018)
* Erectile Dysfunction (2021)  


Asymptomatic Mircoscopic Hematuria (2008)
==== Functional ====


Kidney Follow-up Localized RCC (2018)
* Neurogenic Lower Urinary Tract Dysfunction (2019)
* Male LUTS/BPH (2018)
* CUA/AUA Mesh Position Statement (2019)
* Overactive Bladder (2017)


Cystic Renal Lesions (2017)
==== Infections and Inflammation ====


Small Renal Masses (2015)
* CUA/AUA Recurrent UTI (2019)
* Antibiotic Prophylaxis (2015)
* Chronic Scrotal Pain (2018)
* Interstitial Cystitis (2016)


Surgical Management of RCC (2014)
==== Infertility ====


RCC Genetic Screening (2013)
* Azoospermia (2015)


Non-oncology
==== Pediatrics ====


Andrology Peyronie's Disease (2018)
* Circumcision (2018)
* Antenatal hydronephrosis (2017)
* Cryptorchidism (2017)
* Multicystic Dysplastic Kidney in the Neonate (2015)


Erectile Dysfunction (2021)
==== Stones ====


Functional Neurogenic Lower Urinary Tract Dysfunction (2019)
* Evaluation and Medical Management of Stones (2016)
* Ureteral Calculi (2015)


Male LUTS/BPH (2018)
==== Other ====


CUA/AUA Mesh Position Statement (2019)
* Vasectomy (2016)
* Adrenal Mass (2011)
* Radiation-induced Hemorrhagic Cystitis (2018)
* VTE Prophylaxis (2019)  


Overactive Bladder (2017)
==== Contribute ====


Infections and Inflammation CUA/AUA Recurrent UTI (2019)
* Ureteral calculi (2022)
 
* Pediatric bladder dysfunction (2021)
Antibiotic Prophylaxis (2015)
* Sporadic angiomyolipomas (2020)
 
* Male urethral stricture (2020)
Chronic Scrotal Pain (2018)
* Catheter use (2020)
 
* Renal mass biopsy (2019)
Interstitial Cystitis (2016)
* Pheochromocytoma surveillance (2019)
 
* Pediatric hemorrhagic cystitis (2019)
Infertility Azoospermia (2015)
 
Pediatrics Circumcision (2018)
 
Antenatal hydronephrosis (2017)
 
Cryptorchidism (2017)
 
Multicystic Dysplastic Kidney in the Neonate (2015)
 
Stones Evaluation and Medical Management of Stones (2016)
 
Ureteral Calculi (2015)
 
Other Vasectomy (2016)
 
Adrenal Mass (2011)
 
Radiation-induced Hemorrhagic Cystitis (2018)
 
VTE Prophylaxis (2019)
 
Contribute
 
Ureteral calculi (2022)
 
Pediatric bladder dysfunction (2021)
 
Sporadic angiomyolipomas (2020)
 
Male urethral stricture (2020)
 
Catheter use (2020)
 
Renal mass biopsy (2019)
 
Pheochromocytoma surveillance (2019)
 
Pediatric hemorrhagic cystitis (2019)

Revision as of 08:31, 9 December 2021

AUA

Oncology

Prostate

  • Advanced Prostate Cancer (2020)
  • Adjuvant and Salvage Radiotherapy After Prostatectomy (2019)
  • Prostate Cancer Screening (2018)
  • Clinically Localized Prostate Cancer (2017)

Bladder

  • Microscopic Hematuria (2020)
  • Muscle-invasive Bladder Cancer (2017)
  • Non-muscle Invasive Bladder Cancer (2016)

Kidney

  • Renal Mass and Localized Renal Cancer (2021)

Testicular

  • (2019) Included in Testicular Tumours Chapter Notes

Non-oncology

Andrology

  • Testosterone Deficiency (2018)
  • Erectile Dysfunction (2018)
  • Peyronie's Disease (2015)

Functional

  • Surgical Management BPH (2018)
  • AUA/CUA Mesh Position Statement (2019)
  • Incontinence after Prostate Therapy (2019)
  • Female SUI (2017)

Infections and Inflammation

  • AUA/CUA Recurrent UTI (2019)
  • Pediatrics Vesicoureteral Reflux (2017)

Stones

  • Evaluation and Medical Management of Stones (2019)
  • Stone Surgery (2016)

Other

  • Urotrauma (2020)
  • Male Urethral Stricture (2016)
  • Vasectomy (2015)

Contribute

  • BPH (2021)
  • Infertility (2021)
  • Priapism (2021)
  • OAB (2019)
  • Antibiotic Prophylaxis (2019)

CUA

Oncology

Prostate

  • Castrate-resistant Prostate Cancer (2021)
  • Androgen Deprivation Therapy: Adverse Events & Management (2021)
  • Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020)
  • Testosterone Suppression (2018)
  • Prostate Cancer Screening (2017)
  • Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017)
  • Prostate Cancer Active Surveillance (2015)

Bladder

  • Non-muscle Invasive Bladder Cancer (2021)
  • Advanced and Metastatic Urothelial Cancer (2019)
  • Muscle-invasive Bladder Cancer (2019)
  • Asymptomatic Mircoscopic Hematuria (2008)

Kidney

  • Follow-up Localized RCC (2018)
  • Cystic Renal Lesions (2017)
  • Small Renal Masses (2015)
  • Surgical Management of RCC (2014)
  • RCC Genetic Screening (2013)

Non-oncology

Andrology

  • Peyronie's Disease (2018)
  • Erectile Dysfunction (2021)

Functional

  • Neurogenic Lower Urinary Tract Dysfunction (2019)
  • Male LUTS/BPH (2018)
  • CUA/AUA Mesh Position Statement (2019)
  • Overactive Bladder (2017)

Infections and Inflammation

  • CUA/AUA Recurrent UTI (2019)
  • Antibiotic Prophylaxis (2015)
  • Chronic Scrotal Pain (2018)
  • Interstitial Cystitis (2016)

Infertility

  • Azoospermia (2015)

Pediatrics

  • Circumcision (2018)
  • Antenatal hydronephrosis (2017)
  • Cryptorchidism (2017)
  • Multicystic Dysplastic Kidney in the Neonate (2015)

Stones

  • Evaluation and Medical Management of Stones (2016)
  • Ureteral Calculi (2015)

Other

  • Vasectomy (2016)
  • Adrenal Mass (2011)
  • Radiation-induced Hemorrhagic Cystitis (2018)
  • VTE Prophylaxis (2019)

Contribute

  • Ureteral calculi (2022)
  • Pediatric bladder dysfunction (2021)
  • Sporadic angiomyolipomas (2020)
  • Male urethral stricture (2020)
  • Catheter use (2020)
  • Renal mass biopsy (2019)
  • Pheochromocytoma surveillance (2019)
  • Pediatric hemorrhagic cystitis (2019)
Retrieved from "https://urologyschool.com/wikiuro/index.php?title=Guidelines&oldid=15"